Evaluation of E1-Mutant Adenoviruses as Conditionally Replicating Agents for Cancer Therapy
Open Access
- 30 November 2000
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 2 (5) , 485-495
- https://doi.org/10.1006/mthe.2000.0206
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Consequences of disruption of the interaction between p53 and the larger adenovirus early region 1B protein in adenovirus E1 transformed human cellsOncogene, 2000
- Definition of a major p53 binding site on Ad2E1B58K protein and a possible nuclear localization signal on the Ad12E1B54K proteinOncogene, 1999
- Complementary adenoviral vectors for oncolysisCancer Gene Therapy, 1999
- DNA sequence of the deletion/insertion in early region 3 of Ad5 dl309Virus Research, 1995
- Aberrations of p16Ink4 and retinoblastoma tumour‐suppressor genes occur in distinct sub‐sets of human cancer cell linesInternational Journal of Cancer, 1995
- Assessment of Recombinant Adenoviral Vectors for Hepatic Gene TherapyHuman Gene Therapy, 1993
- Adenovirus–mediated in vivo gene transfer and expression in normal rat liverNature Genetics, 1992
- Retinoblastoma protein switches the E2F site from positive to negative elementNature, 1992
- Individual adenovirus E1B proteins induce transformation independently but by additive pathwaysJournal of General Virology, 1991
- Characteristics of a Human Cell Line Transformed by DNA from Human Adenovirus Type 5Journal of General Virology, 1977